Capital Fund Management »

C4 Therapeutics shares owned by Capital Fund Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Capital Fund Management from 13F filings

Historical chart of Capital Fund Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Capital Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $627k 77k 8.17

More positions owned by Capital Fund Management

NVIDIA Corporation Call Option (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
JPMorgan Chase & Co. Call Option (JPM)
Microsoft Corporation Call Option (MSFT)
Bank of America Corporation (BAC)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. Call Option (LLY)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Paypal Holdings (PYPL)
Tesla Motors Call Option (TSLA)
Super Micro Computer Call Option (SMCI)
Citigroup Com New (C)

View all positions for Capital Fund Management

Top funds holding C4 Therapeutics

State Street Corporation
RA Capital Management
Daniel D. Thurber
Lynx1 Capital Management
Commodore Capital
Vanguard Group
Soleus Capital Management
Balyasny Asset Management
T. Rowe Price Associates
Bank of America Corporation
Silverarc Capital Management
Two Sigma Advisers
Arrowpoint Asset Management
Goldman Sachs Group
TCG Crossover Management

View all funds holding C4 Therapeutics